Stoke Therapeutics Comes Out of Seed Mode With $40M and Ex-Sarepta CEO at Its Helm Post author:Sam Post published:January 3, 2018 Post category:BioPharma The Series A round was entirely funded by founding investor Apple Tree Partners. Source: BioSpace You Might Also Like Theranos Serves as a Cautionary Tale for Biotech Funding March 15, 2018 <b>J.P. Morgan</b>???s <b>Commercial Bank</b> Expands Life Sciences Team To Serve Fast-Growing Industry Team Adds Experienced Bankers And Expands To Key U.S. Markets July 26, 2017 How This Little Biopharma Could Beat Amgen, Teva to the Migraine Finish Line January 16, 2018
<b>J.P. Morgan</b>???s <b>Commercial Bank</b> Expands Life Sciences Team To Serve Fast-Growing Industry Team Adds Experienced Bankers And Expands To Key U.S. Markets July 26, 2017
